nach oben

Indian Journal of Hematology and Blood Transfusion

Erschienen in:

01.04.2020 | Correspondence

Molecular Characterization of G6PD Deficiency at a North Indian Centre: Implications for Diagnostic Testing Laboratories in Different Regions of India

verfasst von: Namrata Singh, Alpeshkumar Bipinbhai Kapadia, Prashant Sharma, Reena Das, Karuna Jain, Man Updesh Singh Sachdeva, Alka Rani Khadwal, Amanjit Bal, Neelam Varma

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Excerpt

Sir, …

Arunachalam AK, Sumithra S, Maddali M, Fouzia NA, Abraham A, George B, Edison ES (2019) Molecular characterization of G6PD deficiency: report of three novel G6PD variants. Indian J Hematol Blood Transfus. https://doi.org/10.1007/s12288-019-01205-7CrossRefPubMed

Kaeda JS, Chhotray GP, Ranjit MR, Bautista JM, Reddy PH, Stevens D, Naidu JM, Britt RP, Vulliamy TJ, Luzzatto L, Mason PJ (1995) A new glucose-6-phosphate dehydrogenase variant, G6PD Orissa (44 Ala-Gly), is the major polymorphic variant in tribal populations in India. Am J Hum Genet 57:1335–1341PubMedPubMedCentral

Hue NT, Charlieu JP, Chau TT, Day N, Farrar JJ, Hien TT, Dunstan SJ (2009) Glucose-6-phosphate dehydrogenase (G6PD) mutations and haemoglobinuria syndrome in the Vietnamese population. Malar J 8:152CrossRef

Leiden Open Variation Database for G6PD. https://databases.lovd.nl/shared/variants/G6PD/unique. Accessed 12 Mar 2020

Sukumar S, Mukherjee MB, Colah RB, Mohanty D (2004) Molecular basis of G6PD deficiency in India. Blood Cells Mol Dis 33:141–145CrossRef

Nishank SS, Chhotray GP, Kar SK, Ranjit MR (2008) Molecular variants of G6PD deficiency among certain tribal communities of Orissa, India. Ann Hum Biol 35:355–361CrossRef

Chalvam R, Kedar PS, Colah RB, Ghosh K, Mukherjee MB (2008) A novel R198H mutation in the glucose-6-phosphate dehydrogenase gene in the tribal groups of the Nilgiris in Southern India. J Hum Genet 53:181–184CrossRef

Tripathi P, Agarwal S, Muthuswamy S (2019) Prevalence and genetic characterization of glucose-6-phosphate dehydrogenase deficiency in anemic subjects from Uttar Pradesh, India. J Pediatr Genet 8:47–53CrossRef

Devendra R, Gupta V, Biradar SS et al (2020) G6PD A- is the major cause of G6PD deficiency among the Siddis of Karnataka, India. Ann Hum Biol 47:55–58CrossRef

10.

Bharti RS, Vashisht K, Ahmed N, Nayak A, Pande V, Mishra N (2020) First report of glucose-6-phosphate dehydrogenase (G6PD) variants (Mahidol and Acores) from malaria-endemic regions of northeast India and their functional evaluations in-silico. Acta Trop 202:105252CrossRef

Titel: Molecular Characterization of G6PD Deficiency at a North Indian Centre: Implications for Diagnostic Testing Laboratories in Different Regions of India
verfasst von: Namrata Singh
Alpeshkumar Bipinbhai Kapadia
Prashant Sharma
Reena Das
Karuna Jain
Man Updesh Singh Sachdeva
Alka Rani Khadwal
Amanjit Bal
Neelam Varma
Publikationsdatum: 01.04.2020
Verlag: Springer India
Erschienen in: Indian Journal of Hematology and Blood Transfusion / Ausgabe 4/2020
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI: https://doi.org/10.1007/s12288-020-01275-y

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Molecular Characterization of G6PD Deficiency at a North Indian Centre: Implications for Diagnostic Testing Laboratories in Different Regions of India

Excerpt

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2020

Surveillance of Transfusion Related Adverse Reactions in a Tertiary Care Centre in Bangalore: A 4-Year Hemovigilance Initiative

Splenectomy Modulates the Erythrocyte Turnover and Basigin (CD147) Expression in Mice

How to Use a Prioritised Approach for Treating Hematological Disorders During the COVID-19 Pandemic in India?

Peri-transplant Stem Cell Kinetics After Daratumumab-Based Induction in Patients with Multiple Myeloma: Response to Mishra et al

The Efficacy of Cladribine (2-CdA) in Advanced Systemic Mastocytosis

A Pilot Study to Assess Transfusion Transmission of Hepatitis C Virus

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie